Related Experiment Video
Updated: May 27, 2026

Isolation and Expansion of Mesenchymal Stem/Stromal Cells Derived from Human Placenta Tissue
Published on: June 6, 2016
Placental membrane as a source of mesenchymal stem cells
I Birgitta Sundell1, Prasad Koka
1Laboratory of Stem Cell Biology, Torrey Pines Institute for Molecular Studies, 3550 General Atomics Court, San Diego, California 92121, USA. bsundell@med.wayne.edu
Abstract:
Non-embryonic stem cells have the potential for being used in therapeutic attempts to develop treatments for human diseases and injuries. There is an increasing demand for non invasive treatments for a number of diseases and disorders that strike and disable relatively young people that would otherwise have many active years ahead. As longevity increases and we face new challenges in treating patients who suffers from disorders that reduces their quality of life already at middle age. Simple, secure methods to isolate non-embryonic stem cells from different tissues is one step towards making those treatments available to people suffering from Parkinson's disease, spinal cord injury, stroke, burns, heart disease, diabetes, osteoarthritis, and rheumatoid arthritis.
Related Concept Videos
Mesenchymal Stem Cells
Embryonic Connective Tissues
The mesenchyme is the first connective tissue that emerges in the developing embryo. It consists of loosely arranged multipotent mesenchymal cells and reticular fibers in the extracellular matrix. This loose arrangement allows easy migration of cells, which is essential for germ layer positioning, patterning, and organ morphogenesis during embryonic development. Mesenchyme is...

